Since the ACT for ALS passed, does this mean that patients will be able to get access to Nurown to treat their MS? I don't think the bill lets ALS patients access Nurown since the FDA did not pass their phase 3 trials but Nurown did pass their phase 2 trials for MS and is still in play with an upcoming phase 3 trial.
The ACT for ALS Act would fund essential research into fast-progressing rare neurodegenerative and terminal diseases, like amyotrophic lateral sclerosis (ALS), and early access to promising investigational therapies for patients suffering from them and would authorize $100 million annually to implement these priorities.
Market Data 
Markets 
AI
